Siwa Therapeutics
  • Home
  • Leadership
  • Science
    • Senescence
    • Diseases
  • Data
    • SIWA 318
    • Data
    • Other Products
  • Media
    • News
    • Videos
  • Partners
  • Contact

Month: September 2019

Home / 2019 / September
26Sep 2019 by Erick ALverado

In the News: Forbes

In The News
SIWA therapeutics was mentioned in an article at Forbes! See what they had to say about senolytic therapies and the future of aging.
Read More

Recent Posts

  • In the News: Forbes
  • SIWA Therapeutics: A New Supernova to Discover!
  • DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD
  • Third Annual Healthspan Extension Policy and Regulation Workshop
  • Second Annual Healthspan Extension Policy and Regulation Workshop

Archives

  • September 2019
  • March 2019
  • April 2018
  • January 2018
  • June 2017
  • May 2017
  • October 2016

Categories

  • Events
  • In The News
  • Press Releases

About Us

SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.

Recent News

  • In the News: Forbes
  • SIWA Therapeutics: A New Supernova to Discover!
  • DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD

JOIN OUR MAILING LIST

Navigation

  • Home
  • Leadership
  • Science
    • Senescence
    • Diseases
  • Data
    • SIWA 318
    • Data
    • Other Products
  • Media
    • News
    • Videos
  • Partners
  • Contact